article
Characterization of SIS3, a Novel Specific Inhibitor of Smad3, and Its Effect on Transforming Growth Factor-β1-Induced Extracellular Matrix Expression
Molecular Pharmacology · 2005 · Vol. 69(2) · pp. 597–607
Masatoshi Jinnin✉(The University of Tokyo)Hironobu Ihn(Kumamoto University)Kunihiko Tamaki(The University of Tokyo)
TGF-β signaling in diseasesConnective Tissue Growth Factor ResearchKruppel-like factors researchExtracellular matrixTransforming growth factorExpression (computer science)Matrix (chemical analysis)ExtracellularChemistryCell biologyBiologyBiochemistryComputer science
MeSH terms
Cell DifferentiationExtracellular MatrixFibroblastsHumansIsoquinolinesLuciferasesPhosphorylationPromoter Regions, GeneticPyridinesPyrrolesScleroderma, SystemicSkinTransfectionSignal TransductionUp-Regulation
Citations
444
FWCI
2.65
field-weighted impact
References
48
Percentile
90%
vs. same field & year
Citations per year
Cited by
TGF-β in progression of liver disease
Cell and Tissue Research · 2011 · 705 citations
Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment
Biomedicine & Pharmacotherapy · 2018 · 354 citations
References
Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
Molecular Pharmacology · 2002 · 647 citations
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
Journal of Immunological Methods · 1983 · 55,054 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.